Skip Navigation

DRUG RECORD

 

DEMECLOCYCLINE

OVERVIEW
Demeclocycline

 

Demeclocycline is a semisynthetic tetracycline derived from Streptococcus aureofaciens that is used as an antibiotic but perhaps more frequently as an inhibitor of arginine vasopressin in the therapy of hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). While demeclocycline has not been linked specifically to liver injury in the published literature, it is an orally available semisynthetic tetracycline and is likely to cause injury similar to that described for tetracycline, oxytetracycline, and doxycycline. Because it is not commonly used, its potential for causing liver injury may not have been fully defined.

 

Background

Demeclocycline (dem" e kloe sye' kleen) is a tetracycline antibiotic that is used for therapy of mild to moderate infections due to susceptible organisms.  It is also used off-label as therapy of hyponatremia and SIADH. Its mechanism of action in SIADH is not well understood, but it appears to block the binding of arginine vasopressin (ADH) to its receptor. This inhibition of antidiuretic hormone action causes an increase in the secretion of free water without an accompanying increase in sodium loss, which results in an aquaresis and increase in serum sodium concentration.  Demeclocycline is recommended in doses of 600 to 1200 mg daily in two to four divided doses. Demeclocycline is available in tablets of 150 or 300 mg under the commercial name of Declomycin.   Common side effects include indigestion, nausea, diarrhea, headahce, dizziness, glossitis and rash.

 

Hepatotoxicity

No reports of liver injury due to demeclocycline have been published. However, demeclocycline is a tetracycline derivative and is likely to cause liver injury similar to other oral tetracyclines. Both hepatitis and liver failure are mentioned in the product label for demeclocycline but details of the liver injury are not provided.  Finally, demeclocycline causes worsening of kidney function in patients with cirrhosis and should not be used for hyponatremia associated with chronic liver disease.

 

 

 

Drug Class: Tetracyclines

Other drugs within this class:Doxycycline, Minocycline, Oxytetracycline, Tetracycline

 

Top of page


PRODUCT INFORMATION
Demeclocycline

COMPLETE LABELING

FDA product labeling at DailyMed, National Library of Medicine, NIH
Demeclocycline (demeclocycline hydrochloride) – Product Labeling, Barr Laboratories.

Top of page


 

DRUG CAS REGISTRY NO MOLECULAR FORMULA STRUCTURE
Demeclocycline Hydrochloride 64-73-3 C21-H21-Cl-N2-O8.Cl-H Demeclocycline  chemical structure

Top of page


 


OTHER REFERENCE LINKS
Demeclocycline

 

  1. PubMed logoRecent References on Demeclocycline

  2. Clinical Trials logoTrials on Demeclocycline



Top of page